UTI - Master Equity Unit Scheme (Mepus) · Regular · Growth
NAV
₹232.9781
as of 13 Nov 2026
Expense Ratio
—
see scheme documents
AUM
₹2,794 Cr
Lumpsum returns (CAGR)
- 1Y
- -1.07%
- 3Y
- +9.44%
- 5Y
- +7.09%
- Since Inception
- +9.25%
SIP returns (XIRR)
- 1Y
- +8.69%
- 3Y
- +4.78%
- 5Y
- +7.99%
- Since Inception
- +10.43%
Returns calculated from 20 November 2007 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 10 years (Nov 2016 – Nov 2026)
A ₹5,000 monthly SIP for the last 10 years (Nov 2016 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹10,16,672 today — ₹6,00,000 invested, 10.3% XIRR.
₹6,00,000
Invested
₹10,16,672
Value today
10.3%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Nov 2016 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹2,85,071 today (11.1% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Nov 2016 would still hold ₹18,34,043.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Nov 2016 – Nov 2026) (22 Mar 2020) would be ₹3,26,794 today (3.27×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised-0.25
Sharpe Ratio
—
Alpha
—
Beta
-0.24
Sortino
12.30%
Std Dev
-15.46%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Sept 2026- Banks28.40%
- IT - Software8.11%
- Automobiles5.49%
- Petroleum Products5.43%
- Retailing5.43%
- Telecom - Services4.07%
- Construction4.06%
- Finance3.83%
- Consumer Durables2.75%
- Insurance2.39%
- Pharmaceuticals & Biotechnology2.35%
- Aerospace & Defense2.00%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about UTI - Master Equity Unit Scheme (Mepus) · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Portfolio holdings
- 1Hdfc Bank Limited9.10%
- 2Icici Bank Ltd8.93%
- 3Kotak Mahindra Bank Ltd.5.04%
- 4Reliance Industries Ltd.5.03%
- 5Bharti Airtel Ltd.4.07%
- 6Larsen & Toubro Ltd.4.06%
- 7Bajaj Finance Ltd.3.21%
- 8Infosys Ltd.3.18%
- 9Axis Bank Ltd.3.14%
- 10Eternal Limited2.82%
What this fund does
UTI - Master Equity Unit Scheme (Mepus) · Regular · Growth by UTI Mutual Fund is a Other fund that aims to generate optimal returns for investors based on its investment mandate. The fund follows a disciplined investment process aligned with SEBI regulations for the Other category.
About This Fund
UTI - Master Equity Unit Scheme (Mepus) · Regular · Growth is a Other mutual fund offered by UTI Mutual Fund. The fund has been operational for over 20 years. It manages assets worth ₹2,794 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE 100 TRI.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations